Influence of a novel calcium-phosphate coating on the mechanical properties of highly porous collagen scaffolds for bone repair.

Lyophilised collagen scaffolds have shown enormous potential in tissue engineering in a number of areas due to their excellent biological performance. However, they are limited for use in bone tissue engineering due to poor mechanical properties. This paper discusses the development of a calcium-phosphate coating for collagen scaffolds in order to improve their mechanical properties for bone tissue engineering. Pure collagen scaffolds produced in a lyophilization process were coated by immersing them in sodium ammonium hydrogen phosphate (NaNH(4)HPO(4)) followed by calcium chloride (CaCl(2)). The optimal immersing sequence, duration, as well as the optimal solution concentration which facilitated improved mechanical properties of the scaffolds was investigated. The influence of the coating on composition, structural and material properties was analysed. This investigation successfully developed a novel collagen/calcium-phosphate composite scaffold. An increase in the mechanical properties of the scaffolds from 0.3 kPa to up to 90 kPa was found relative to a pure collagen scaffold, while the porosity was maintained as high as 92%, indicating the potential of the scaffold for bone tissue engineering or as a bone graft substitute

Study the effect of increasing Gamma ray doses on some physical properties of Carboxy methyl cellulose

In this study some of the physical properties of Carboxymethyle cellulose dissolves in distilled water with different concentration had been studies before and after irradiation by gamma ray of variable dose (5000rad, 7000rad, 9000rad).These properties are firstly the Rheological properties such as shear viscosity, relative viscosity specific viscosity and reduced viscosity are measured, secondly the mechanical properties such as ultrasonic velocity had been measured at frequency (40KHz). Other mechanical properties had been calculated such as absorption coefficient of ultrasonic waves, relaxation time, relaxation amplitude, specific acoustic impedance, bulk modules and compressibility. The results show that all these properties are affected with variation in density and viscosity because of the intermolecular interactions Gamma radiation made degradation to polymer molecular chains that affect the physical properties as a result ultrasonic absorption increased and molecular weight decreased after irradiation. Keywords: CMC solution, ultrasound technique, degradation, rheological properties, mechanical properties

Development of a collagen calcium-phosphate scaffold as a novel bone graft substitute.

Previous investigations have shown that collagen shows excellent biological performance as a scaffold for tissue engineering. As a primary constituent of bone and cartilage, it demonstrates excellent cell adhesion and proliferation. However, in bone tissue engineering, it has insufficient mechanical properties for implantation in a load-bearing defect. The objective of this preliminary study was to investigate the possibility of developing a collagen/calcium-phosphate composite scaffold which would combine the biological performance and the high porosity of a collagen scaffold with the high mechanical stiffness of a calcium-phosphate scaffold. Collagen scaffolds were produced by a lyophilisation process from a collagen slurry. The scaffolds were soaked for different exposure times in solutions of 0.1 M, 0.5 M or 1.0 M NaNH4HPO4 followed by 0.1 M, 0.5 M or 1.0 M CaCl2. Mechanical tests of each scaffold were performed on a uniaxial testing system. Young\u27s moduli were determined from stress-strain curves. The pore structure and porosity of the scaffolds were investigated using micro-computed tomography. A pure collagen scaffold served as a control. All scaffolds showed a significantly increased compressive stiffness relative to the pure collagen scaffolds. The exposure to the 0.5 M solutions showed significantly superior results compared to the other groups. Analysis of the pore structure indicated a decrease in the overall porosity of the composite scaffolds relative to the controls. Regarding mechanical stiffness and porosity, scaffolds after 1 hour exposure to the 0.5 M solutions showed the best properties for bone tissue engineering. Further work will involve producing a scaffold with a more homogeneous calcium phosphate distribution

Shear design of HSC beams with combination of links and horizontal web steel

The existing recommendations in Eurocode 2 and the British Code of Practice for the shear design of beams are derived from research conducted essentially on normal-strength concrete (NSC) with cube strengths up to 50 MPa, and it was found that the shear strengths of high-strength concrete (HSC) members made with limestone aggregate are below the characteristic resistances of identical NSC members. Previous experimental tests have also shown that significant differences exist in the angle of crack of shear failure of NSC and HSC. This paper presents data from five beam tests, which demonstrate that HSC with limestone aggregate has a reduced shear strength compared with NSC made with gravel and thus shows a gap in knowledge in the design approach to shear resistance of HSC beams. Previous investigations have suggested that horizontal web steels can contribute to the overall shear resistance of a reinforced concrete member in conjunction with the other constituents, concrete, tension and shear steel. The paper also presents data from tests on 11 beam tests and shows that the shear resistance of HSC beams is highly dependent on dowel action resulting from horizontal web bars positioned at the centre of the depth of the beam. Past attempts to quantify this dowel action are investigated and an improved design rule is proposed

Prepare and Study Some Mechanical and Electrical Properties of KAl(SO4)2.12H2O as Aqueous Solutions

Some of physical properties of  KAl(SO4)2.12H2O dissolves in distilled water had been studied at different concentrations (0.05% , 0.075% , 0.1% , 0.125 and 0.15 gm./ml) such as (mechanical and electrical properties), the mechanical properties  such as ultrasonic velocity had been measured by ultrasonic waves system at frequency 25 KHz, other mechanical properties had been calculated such as absorption coefficient of ultrasonic waves, relaxation time, relaxation amplitude, specific acoustic impedance, compressibility and bulk modules. The electrical properties such as electrical conductivity, molar conductivity and degree of dissociation were measured by conductivity meter, The results show that the specific acoustic impedance and bulk modules are increasing with the increase of the concentration , absorption coefficient of ultrasonic waves ,compressibility, relaxation time, relaxation amplitude and shear viscosity are decreasing with increase the concentration, also The results show that the conductivity is increasing with increase the concentration. Keywords: KAl(SO4)2.12H2O solution, Electrical properties, Mechanical properties, ultrasound technique.

Quaternary Boundary Optimal Control Problem Dominating by Quaternary Nonlinear Parabolic System

In this paper, our purpose is to study the quaternary continuous classical boundary optimal control vector problem (QCCBOCVP) dominated by the quaternary nonlinear parabolic boundary value problem (QNLPBVP). Under suitable assumptions and with given quaternary continuous classical boundary control vector (QCCBCV), the existence theorem for a unique quaternary state vector solution (QSVS) of the weak form (WF) for the QNLPBVP is stated and demonstrated via the Method of Galerkin and the first compactness theorem. Furthermore, the continuity of the Lipchitz operator between the QSVS of the WF for the QLPBVP and the corresponding QCCBCV is proved. The existence of a quaternary continuous classical boundary optimal control vector (QCCBOVC) is stated and demonstrated under suitable assumptions

The Glasgow-Maastricht foot model, evaluation of a 26 segment kinematic model of the foot

BACKGROUND: Accurately measuring of intrinsic foot kinematics using skin mounted markers is difficult, limited in part by the physical dimensions of the foot. Existing kinematic foot models solve this problem by combining multiple bones into idealized rigid segments. This study presents a novel foot model that allows the motion of the 26 bones to be individually estimated via a combination of partial joint constraints and coupling the motion of separate joints using kinematic rhythms. METHODS: Segmented CT data from one healthy subject was used to create a template Glasgow-Maastricht foot model (GM-model). Following this, the template was scaled to produce subject-specific models for five additional healthy participants using a surface scan of the foot and ankle. Forty-three skin mounted markers, mainly positioned around the foot and ankle, were used to capture the stance phase of the right foot of the six healthy participants during walking. The GM-model was then applied to calculate the intrinsic foot kinematics. RESULTS: Distinct motion patterns where found for all joints. The variability in outcome depended on the location of the joint, with reasonable results for sagittal plane motions and poor results for transverse plane motions. CONCLUSIONS: The results of the GM-model were comparable with existing literature, including bone pin studies, with respect to the range of motion, motion pattern and timing of the motion in the studied joints. This novel model is the most complete kinematic model to date. Further evaluation of the model is warranted

Characterizing the Neurobiological Mechanisms of Action of Exercise and Cognitive–Behavioral Interventions for Rheumatoid Arthritis Fatigue : a magnetic resonance imaging brain study

Open Access via the Wiley/JISC agreement Acknowledgements We would like to thank all the investigators from the original LIFT study, including Kathryn Martin, Lorna Aucott, Neeraj Dhaun, Emma Dures, Stuart R. Gray, Elizabeth Kidd, Vinod Kumar, Karina Lovell, Graeme MacLennan, Paul McNamee, John Norrie, Lorna Paul, Jon Packham, Stefan Siebert, Alison Wearden, and Gary Macfarlane, without whose work this research would not be possible. Furthermore, we thank all the participants who generously supported the LIFT trial. We also acknowledge the contribution of the Trial Steering Committee and Data Monitoring Committee, and Brian Taylor and Mark Forrest (Centre for Healthcare Randomised Trials [CHaRT], University of Aberdeen, Aberdeen, UK) for their technical assistance Funding This study was funded by the Chief Scientist Office (TCS/17/14) and Versus Arthritis (22092).Peer reviewe

The immunomodulatory parasitic worm product ES-62 reduces lupus-associated accelerated atherosclerosis in a mouse model.

ES-62 is an anti-inflammatory phosphorylcholine-containing glycoprotein secreted by the filarial nematode Acanthocheilonema viteae. Accelerated atherosclerosis frequently occurs in systemic lupus erythematosus, resulting in substantial cardiovascular morbidity and mortality. We examined the effects of ES-62 in the gld.apoE(-/-) mouse model of this condition. Treatment with ES-62 did not substantially modulate renal pathology but caused decreased anti-nuclear autoantibody levels. Moreover, a striking 60% reduction in aortic atherosclerotic lesions was observed, with an associated decrease in macrophages and fibrosis. We believe that these latter findings constitute the first example of a defined parasitic worm product with therapeutic potential in atherosclerosis: ES-62-based drugs may represent a novel approach to control accelerated atherosclerosis in systemic lupus erythematosus

A double blind, randomised placebo controlled trial of topical 2% viscous lidocaine in improving oral intake in children with painful infectious mouth conditions

<p>Abstract</p> <p>Background</p> <p>Painful infectious mouth conditions are a common presentation to emergency departments. Although self limiting, painful ulcerative lesions and inflamed mucosa can decrease oral intake and can lead to dehydration. Oral analgesia is of limited efficacy and is often refused by the patient. Despite widespread use of oral 2% viscous lidocaine for many years, there is little evidence for its efficacy as an analgesic and in aiding oral intake in children with painful infectious mouth conditions. This study aims to establish the effectiveness of 2% viscous lidocaine in increasing oral intake in these children by comparing it with placebo.</p> <p>Methods/Design</p> <p>This study is a randomised double-blind placebo controlled trial of children between 6 months and 8 years of age with painful infectious mouth conditions defined as gingivostomatitis (herpetic or non herpetic), ulcerative pharyngitis, herpangina and hand foot and mouth disease as assessed by the treating clinician in association with a history of poor oral fluid intake. It will be conducted at a single tertiary paediatric emergency department in Melbourne Australia.</p> <p>20 patients have already been randomised to receive 2% lidocaine or placebo in a pilot study to determine the sample size in a preplanned adaptive design. A further 80 patients will be randomised to receive either 2% lidocaine or placebo. The placebo agent is identical to lidocaine in terms of appearance, flavour and smell. All clinical and research staff involved, patients and their parents will be blinded to treatment allocation.</p> <p>The primary endpoint is the amount of fluid ingested by each child, expressed in ml/kg, within 60 minutes from the time of administration of the study mixture. Secondary endpoints are the proportion of patients ingesting 5 ml/kg and 10 ml/kg at 30 and 60 minutes after drug administration and the incidence of adverse events. Longer term outcomes will include the proportion of patients requiring hospital admission and length of emergency department stay.</p> <p>Discussion</p> <p>This trial will define the role of 2% lidocaine in the treatment of painful infectious mouth conditions</p> <p>Trial registration</p> <p>The trial is registered with the Australian and New Zealand Clinical Trials Registry - <a href="http://www.anzctr.org.au/ACTRN12609000566235.aspx">ACTRN12609000566235</a>.</p